Hong Kong Insurance Stocks Extend Gains in Afternoon Trading as Interest Rate Adjustments Boost August Life Insurance Sales, Rising Long-Term Rates Help Ease Allocation Pressure

Stock News
2025/09/29

Chinese insurance stocks listed in Hong Kong extended their gains in afternoon trading. As of press time, NCI (01336) rose 6.84% to HK$45.94; CHINA LIFE (02628) gained 5.46% to HK$22.4; CPIC (02601) climbed 4.6% to HK$31.82; and PING AN (02318) advanced 2.96% to HK$53.95.

On the news front, the National Financial Regulatory Administration disclosed premium income data for the insurance industry. From January to August 2025, the insurance industry recorded premium income of RMB 4.7998 trillion, up 9.6% year-on-year. In August alone, the industry's premium income reached RMB 591.3 billion, surging 35.6% year-on-year. Personal insurance premium income in August totaled RMB 464.4 billion, jumping 49.7% year-on-year, with the "rush to buy before discontinuation" effect continuing to be prominent amid the predefined interest rate reduction catalyst. Property insurance premium income was RMB 126.8 billion, up 0.9% year-on-year.

CITIC Securities released a research report stating that the recent slight uptick in long-term interest rates is beneficial for alleviating allocation pressure on insurance companies. The current valuation levels excessively reflect the suppression of future investment returns by low interest rates. Listed insurance companies are actively increasing their allocation to high dividend strategies to hedge against the impact of falling interest rates on net investment yield.

The firm believes that current valuation levels of listed insurance companies remain at low levels with sufficient long-term safety margins. Against the backdrop of stabilizing and rising long-term interest rates, there is still room for valuation recovery among listed insurance companies.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10